Abstract |
The intracellular half-life for retention of the active triphosphate metabolite 1-beta-D-arabinofuranosylcytosine 5'-triphosphate (araCTP) of 1-beta-D-arabinofuranosylcytosine was measured in vitro in blast cells from patients with acute myeloblastic leukemia, acute lymphoblastic leukemia, and T-cell lymphoblastic lymphoma. araCTP accumulation from 1 microM 1-beta-D-arabinofuranosylcytosine in leukemic blast cells was closely correlated with the nucleoside transport capacity as measured by equilibrium binding of [3H]nitrobenzylthioinosine. The half-life of araCTP retention was related to araCTP accumulation only when the level of araCTP was expressed as a percentage of total intracellular 1-beta-D-arabinofuranosylcytosine metabolites. Accumulation of 1-beta-D-arabinofuranosyluracil 5'-monophosphate was inversely related to the half-life of araCTP retention and directly related to dCMP deaminase activity in cell free extracts. No conversion of 1-beta-D-arabinofuranosyluracil to 1-beta-D-arabinofuranosyluracil 5'-monophosphate was detectable in intact cells. The end product of araCTP degradation was 1-beta-D-arabinofuranosyluracil and it is proposed that conversion of 1-beta-D-arabinofuranosylcytosine 5'-monophosphate to 1-beta-D-arabinofuranosyluracil 5'-monophosphate is a step in the degradative pathway of araCTP. However, it is the cells' nucleoside transport capacity which primarily determines the level of intracellular araCTP accumulation.
|
Authors | G P Jamieson, L R Finch, M Snook, J S Wiley |
Journal | Cancer research
(Cancer Res)
Vol. 47
Issue 12
Pg. 3130-5
(Jun 15 1987)
ISSN: 0008-5472 [Print] United States |
PMID | 3472653
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Arabinonucleotides
- Thionucleosides
- Cytarabine
- Guanosine
- 6-(4-nitrobenzylthio)guanosine
- Arabinofuranosylcytosine Triphosphate
- Thioinosine
- DCMP Deaminase
- 4-nitrobenzylthioinosine
|
Topics |
- Arabinofuranosylcytosine Triphosphate
(metabolism)
- Arabinonucleotides
(metabolism)
- Cytarabine
(therapeutic use)
- DCMP Deaminase
(metabolism)
- Guanosine
(analogs & derivatives, pharmacology)
- Half-Life
- Humans
- Kinetics
- Leukemia, Lymphoid
(metabolism)
- Leukemia, Myeloid, Acute
(metabolism)
- Lymphocytes
(metabolism)
- Phosphorylation
- Thioinosine
(analogs & derivatives, pharmacology)
- Thionucleosides
(pharmacology)
|